ANNOUNCEMENT {#s1}
============

Klebsiella pneumoniae is a well-known opportunistic pathogen that causes community-acquired and health care-associated infections ([@B1], [@B2]). A capsular polysaccharide is the major virulence factor of K. pneumoniae ([@B1], [@B3]). Of the number of documented capsular types, strains of the K1 type, along with those of the K2 type, are the most virulent human pathogens ([@B4], [@B5]). We previously reported genome sequences of 10 strains of the K. pneumoniae K2 type, isolated from patients in an infectious disease hospital and neurosurgical intensive care unit ([@B6]). In this study, we report the genome sequences of K1-type K. pneumoniae strains isolated in the same hospitals ([@B7]).

Bacteria were grown at 37°C on nutrient medium no. 1 (Obolensk, Russia). Genomic DNA was isolated using the phenol-chloroform extraction and ethanol precipitation methods (<https://fdocuments.in/download/phenol-chloroform-isoamyl-alcohol-pci-dna-isoamyl-alcohol-pci-dna-extraction>). Draft genome sequencing was performed using Nextera XT DNA sample preparation kits, a MiSeq reagent kit v.3 (300 cycles), and the MiSeq platform (Illumina). For each genome, the paired reads without filtering were *de novo* assembled with Unicycler v.0.4.7 ([@B8]). Default parameters were used for all software. The resulting draft genome sizes ranged from 5.52 to 5.81 Mb, with GC contents ranging from 56.9 to 57.2%. The final assemblies were annotated with the NCBI Prokaryotic Genome Annotation Pipeline ([@B9]), resulting in the identification of total numbers of genes ranging from 6,147 to 5,453 ([Table 1](#tab1){ref-type="table"}). Raw reads were used for multilocus sequence type (MLST) analysis with MLST v.2.0 (<https://cge.cbs.dtu.dk/services/MLST/>). All strains were assigned to sequence type 23.

###### 

Strain-identifying information and basic statistics on assemblies and annotations

  Strain name                                      Raw data SRA accession no.                                  GenBank accession no.                                               No. of reads   *N*~50~ (bp)   No. of contigs   Genome size (bp)   Total no. of genes   GC content (%)   Genome coverage (×)   Plasmid replicon type(s)                           Drug resistance phenotype and predicted resistance gene(s)[^*b*^](#ngtab1.2){ref-type="table-fn"}                                                                                                                                                                
  ------------------------------------------------ ----------------------------------------------------------- ------------------------------------------------------------------- -------------- -------------- ---------------- ------------------ -------------------- ---------------- --------------------- -------------------------------------------------- --------------------------------------------------------------------------------------------------- -------------------------------------------------------- ------------------------------------------- -------- --------- ---------------- ---------- -------- --------------------
  KPS73[^*a*^](#ngtab1.1){ref-type="table-fn"}     [SRR9208895](https://www.ncbi.nlm.nih.gov/sra/SRR9208895)   [VKCS00000000](https://www.ncbi.nlm.nih.gov/nuccore/VKCS00000000)   807,366        220,354        74               5,558,879          5,451                57.2             17                    IncHI1B                                            *bla*~SHV-190~                                                                                                                                               *oqxA*, *oqxB*                              *fosA*                                                  
  KPB1802[^*a*^](#ngtab1.1){ref-type="table-fn"}   [SRR9208897](https://www.ncbi.nlm.nih.gov/sra/SRR9208897)   [VKCV00000000](https://www.ncbi.nlm.nih.gov/nuccore/VKCV00000000)   729,262        157,398        74               5,620,879          5,519                57.0             25                    IncHI1B                                            *bla*~SHV-190~                                                                                                                                               *oqxA*, *oqxB*                              *fosA*                                                  
  KPi1683[^*a*^](#ngtab1.1){ref-type="table-fn"}   [SRR9208901](https://www.ncbi.nlm.nih.gov/sra/SRR9208901)   [VKCX00000000](https://www.ncbi.nlm.nih.gov/nuccore/VKCX00000000)   751,372        180,119        78               5,580,912          5,452                57.2             35                    IncHI1B                                            *bla*~SHV-190~                                                                                                                                               *oqxA*, *oqxB*                              *fosA*                                                  
  KPi3695                                          [SRR9208904](https://www.ncbi.nlm.nih.gov/sra/SRR9208904)   [VTRP00000000](https://www.ncbi.nlm.nih.gov/nuccore/VTRP00000000)   592,094        154,881        77               5,573,189          5,453                57.1             27                    IncHI1B                                            *bla*~SHV-190~                                                                                                                                               *oqxA*, *oqxB*                              *fosA*                                                  
  KPB1493[^*a*^](#ngtab1.1){ref-type="table-fn"}   [SRR9208896](https://www.ncbi.nlm.nih.gov/sra/SRR9208896)   [VKCT00000000](https://www.ncbi.nlm.nih.gov/nuccore/VKCT00000000)   501,624        56,694         300              5,521,123          5,669                57.0             22                    IncHI1B, IncFII(K)                                 *bla*~SHV-190~, *bla*~CTXM15~, *bla*~TEM-1B~, *bla*~OXA-1~                                          *aac(6\')-Ib-cr*, *aph(6)-Id*, *aph(3\'\')-Ib*           *aac(6\')-Ib-cr*, *qnrB1*                   *fosA*   *catB3*   *sul2*           *dfrA14*   *tetA*   
  KPB3188                                          [SRR9208900](https://www.ncbi.nlm.nih.gov/sra/SRR9208900)   [VKCU00000000](https://www.ncbi.nlm.nih.gov/nuccore/VKCU00000000)   717,240        105,254        202              5,614,863          5,675                57.0             31                    IncHI1B, IncFII(K), IncL/M                         *bla*~SHV-190~, *bla*~CTX-M-15~, *bla*~TEM-1B~, *bla*~OXA-1~, *bla*~OXA-48~                         *aac(6\')-Ib-cr*, *aph(6)-Id*, *aph(3\'\')-Ib*           *aac(6\')-Ib-cr*, *oqxA*, *oqxB*, *qnrB1*   *fosA*   *catB3*   *sul2*           *dfrA14*   *tetA*   
  KPB1103[^*a*^](#ngtab1.1){ref-type="table-fn"}   [SRR9208898](https://www.ncbi.nlm.nih.gov/sra/SRR9208898)   [VKCW00000000](https://www.ncbi.nlm.nih.gov/nuccore/VKCW00000000)   660,384        97,397         151              5,594,258          5,644                57.2             29                    IncHI1B, IncFII(K), IncL/M                         *bla*~SHV-190~, *bla*~CTX-M-15~, *bla*~TEM-1B~, *bla*~OXA-1~, *bla*~OXA-48~                         *aac(6\')-Ib-cr*, *aph(6)-Id*, *aph(3\'\')-Ib*           *aac(6\')-Ib-cr*, *oqxA*, *oqxB*, *qnrB1*   *fosA*   *catB3*   *sul2*           *dfrA14*   *tetA*   
  KPB475[^*a*^](#ngtab1.1){ref-type="table-fn"}    [SRR9208903](https://www.ncbi.nlm.nih.gov/sra/SRR9208903)   [VTRO00000000](https://www.ncbi.nlm.nih.gov/nuccore/VTRO00000000)   980,374        151,126        143              5,661,349          5,714                56.9             42                    IncHI1B, IncFII(K), IncL/M                         *bla*~SHV-190~, *bla*~CTX-M-15~, *bla*~TEM-1B~, *bla*~OXA-1~, *bla*~OXA-48~                         *aac(6\')-Ib-cr*, *aph(6)-Id*, *aph(3\'\')-Ib*           *aac(6\')-Ib-cr*, *oqxA*, *oqxB*, *qnrB1*   *fosA*   *catB3*   *sul2*           *dfrA14*   *tetA*   
  KPB470                                           [SRR9208899](https://www.ncbi.nlm.nih.gov/sra/SRR9208899)   [VTRN00000000](https://www.ncbi.nlm.nih.gov/nuccore/VTRN00000000)   762,324        86,243         223              5,490,022          5,582                57.2             31                    IncHI1B, IncFII(K), IncL/M                         *bla*~SHV-190~, *bla*~CTX-M-15~, *bla*~TEM-1B~, *bla*~OXA-1~, *bla*~OXA-48~                         *aac(6\')-Ib-cr*, *aph(6)-Id*, *aph(3\'\')-Ib*           *aac(6\')-Ib-cr*, *oqxA*, *oqxB*, *qnrB1*   *fosA*   *catB3*   *sul2*           *dfrA14*   *tetA*   
  KPB463-13                                        [SRR9208902](https://www.ncbi.nlm.nih.gov/sra/SRR9208902)   [VTRQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/VTRQ00000000)   688,138        99,224         245              5,811,379          5,966                56.9             29                    IncHI1B, IncFII(K), IncL/M, Col440I, IncFIA(HI1)   *bla*~SHV-190~, *bla*~CTX-M-15~, *bla*~TEM-1B~, *bla*~OXA-1~, *bla*~OXA-48~                         *aac(6\')-Ib-cr*, *aph(6)-Id*, *aph(3\'\')-Ib*, *armA*   *aac(6\')-Ib-cr*, *oqxA*, *oqxB*, *qnrB1*   *fosA*   *catB3*   *sul1*, *sul2*   *dfrA14*   *tetA*   *msr*(E), *mph*(E)

![](MRA.01250-19-t0001)

Additional information on strain characterization is provided in a previous publication ([@B7]).

BLA, beta-lactams; AMI, aminoglycoside; FQN, fluoroquinolone; FOS, fosfomycin; PHE, phenicol; SUL, sulphonamide; TRI, trimethoprim; TET, tetracycline; MLS, macrolide, lincosamide, and streptogramin B. Resistance phenotype was determined using a Vitek 2 Compact instrument (bioMérieux, France). ResFinder v.2.1 ([@B14]) was used to determine the presence of resistance genes.

Five types of plasmid replicons were determined in the assembled genomes using PlasmidFinder v.2.1 ([@B10]) ([Table 1](#tab1){ref-type="table"}). All of the strains harbored a pLVPK-like virulence plasmid ([@B11]) containing an IncHI1B replicon, genes *rpmA* and/or *rmpA2* encoding regulators of the mucoid phenotype specific to hypervirulent K. pneumoniae, and siderophore gene clusters *iucABCD*, *iutA*, and *iroBCDN*. Important differences in antibiotic resistance phenotype and resistance genes between strains with different plasmid profiles were revealed ([Table 1](#tab1){ref-type="table"}). The strains harboring only a pLVPK-like plasmid were resistant to ampicillin, fluoroquinolone, and fosfomycin due to the presence of the chromosomal genes *bla*~SHV-190~, *oqxA* and/or *oqxB*, and *fosA*, respectively. Strain KPB1493 acquired the IncFII(K) plasmid, which additionally carried genes providing resistance to aminoglycosides, phenicols, sulfonamides, trimethoprim, and tetracyclines. Strains KPB3188, KPB1103, KPB475, KPB470, and KPB463-13 harbored the IncL/M plasmid carrying the carbapenemase gene *bla*~OXA-48~ and demonstrate resistance to carbapenems. The extrachromosomal genome of strain KPB463-13 and its resistance phenotype are even more complicated because of the presence of two more plasmids, namely a cryptic plasmid, Col440I, that was detected in many extended-spectrum beta-lactamase (ESBL)-producing and carbapenem-resistant K. pneumoniae strains ([@B12]), and an IncFIA(HI1) plasmid that is possibly associated with *armA*, *sul1*, *msr*(E), and *mph*(E) genes. It is important to emphasize the identification of epidemiologically significant genes encoding the *bla*~OXA-48~ carbapenemase and the bifunctional enzyme aac(6′)-Ib-cr.

The presented diversity of the genomes in the K. pneumoniae strains reflects the important role of plasmids in the horizontal transfer of resistance genes, which is the prevalent mechanism of originating antimicrobial resistance acquisition in bacterial pathogens ([@B13]).

Data availability. {#s1.1}
------------------

Genome sequences were deposited in the GenBank/ENA/DDBJ databases under the accession numbers listed in [Table 1](#tab1){ref-type="table"}.
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